The crosstalk between epilepsy and dementia : A systematic review and meta-analysis
Copyright © 2024 Elsevier Inc. All rights reserved..
BACKGROUND: Epilepsy and dementia are bidirectional. The purpose of this review was to investigate the epidemiological characteristics of and to identify the risk factors for epilepsy in patients with dementia and dementia in patients with epilepsy.
METHODS: We retrieved the PubMed, Embase, Cochrane and Web of Science databases through January 2023. Two individuals screened the articles, extracted the data, and used a random effects model to pool the estimates and 95% confidence intervals (CIs).
RESULTS: From 3475 citations, 25 articles were included. The prevalence of seizures/epilepsy was 4% among dementia patients and 3% among Alzheimer's disease (AD) patients. For vascular dementia, Lewy body dementia, and frontotemporal dementia, the pooled period prevalence of seizures/epilepsy was 6%, 3%, and 2%, respectively. Baseline early-onset AD was associated with the highest risk of 5-year epilepsy (pooled hazard ratios: 4.06; 95% CI: 3.25-5.08). Dementia patients had a 2.29-fold greater risk of seizures/epilepsy than non-dementia patients (95% CI: 1.37-3.83). Moreover, for baseline epilepsy, the pooled prevalence of dementia was 17% (95% CI: 10-25%), and that of AD was 15% (95% CI: 9-21%). The pooled results suggested that epilepsy is associated with a greater risk of dementia (risk ratio: 2.83, 95% CI: 1.64-4.88).
CONCLUSIONS: There are still gaps in epidemiology regarding the correlation between dementia types and epilepsy, vascular risk factors, and the impact of antiseizure medication or cognitive improvement drugs on epilepsy and AD comorbidity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:152 |
---|---|
Enthalten in: |
Epilepsy & behavior : E&B - 152(2024) vom: 31. März, Seite 109640 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Lu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Dementia |
---|
Anmerkungen: |
Date Completed 05.03.2024 Date Revised 05.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.yebeh.2024.109640 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367908190 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367908190 | ||
003 | DE-627 | ||
005 | 20240305232303.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240202s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.yebeh.2024.109640 |2 doi | |
028 | 5 | 2 | |a pubmed24n1317.xml |
035 | |a (DE-627)NLM367908190 | ||
035 | |a (NLM)38301455 | ||
035 | |a (PII)S1525-5050(24)00021-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Lu |e verfasserin |4 aut | |
245 | 1 | 4 | |a The crosstalk between epilepsy and dementia |b A systematic review and meta-analysis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.03.2024 | ||
500 | |a Date Revised 05.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: Epilepsy and dementia are bidirectional. The purpose of this review was to investigate the epidemiological characteristics of and to identify the risk factors for epilepsy in patients with dementia and dementia in patients with epilepsy | ||
520 | |a METHODS: We retrieved the PubMed, Embase, Cochrane and Web of Science databases through January 2023. Two individuals screened the articles, extracted the data, and used a random effects model to pool the estimates and 95% confidence intervals (CIs) | ||
520 | |a RESULTS: From 3475 citations, 25 articles were included. The prevalence of seizures/epilepsy was 4% among dementia patients and 3% among Alzheimer's disease (AD) patients. For vascular dementia, Lewy body dementia, and frontotemporal dementia, the pooled period prevalence of seizures/epilepsy was 6%, 3%, and 2%, respectively. Baseline early-onset AD was associated with the highest risk of 5-year epilepsy (pooled hazard ratios: 4.06; 95% CI: 3.25-5.08). Dementia patients had a 2.29-fold greater risk of seizures/epilepsy than non-dementia patients (95% CI: 1.37-3.83). Moreover, for baseline epilepsy, the pooled prevalence of dementia was 17% (95% CI: 10-25%), and that of AD was 15% (95% CI: 9-21%). The pooled results suggested that epilepsy is associated with a greater risk of dementia (risk ratio: 2.83, 95% CI: 1.64-4.88) | ||
520 | |a CONCLUSIONS: There are still gaps in epidemiology regarding the correlation between dementia types and epilepsy, vascular risk factors, and the impact of antiseizure medication or cognitive improvement drugs on epilepsy and AD comorbidity | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Dementia | |
650 | 4 | |a Epidemiology | |
650 | 4 | |a Epilepsy | |
650 | 4 | |a Meta-analysis | |
650 | 4 | |a Seizures | |
700 | 1 | |a Yang, Wenqian |e verfasserin |4 aut | |
700 | 1 | |a Yang, Fei |e verfasserin |4 aut | |
700 | 1 | |a Yu, Yanying |e verfasserin |4 aut | |
700 | 1 | |a Xu, Tingwan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Dan |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Qingqing |e verfasserin |4 aut | |
700 | 1 | |a Wu, Qian |e verfasserin |4 aut | |
700 | 1 | |a Han, Yanbing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Epilepsy & behavior : E&B |d 2000 |g 152(2024) vom: 31. März, Seite 109640 |w (DE-627)NLM123848776 |x 1525-5069 |7 nnns |
773 | 1 | 8 | |g volume:152 |g year:2024 |g day:31 |g month:03 |g pages:109640 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.yebeh.2024.109640 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 152 |j 2024 |b 31 |c 03 |h 109640 |